US5310903A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Imidazolidyl rapamycin derivatives
Assignee: Merck and Co Inc
•
Filing: 1993-03-05
•
Granted: 1994-05-10
•
Expires: 2013-03-05
Abstract
Abstract Imidazolidyl rapamycin derivatives of the general structural Formula I: <IMAGE> I have been prepared from suitable precursors by alkylation and/or arylation at C-42 and/or C-31. These compounds are useful in a mammalian host for the treatment of autoimmune diseases and diseases of inflammation, infectious diseases, the prevention of rejection of foreign organ transplants and the treatment of solid tumors.
Inventors
- 👤 Mark Goulet
- 👤 William H. Parsons
- 👤 Matthew J. Wyvratt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 18:49
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
2135 words
A compound of formula I: ##STR20## or a pharmaceutically acceptable salt thereof, wherein: R 1 is selected from the group consisting of: ##STR21## wherein G is N--R 6 , O, S, SO, or SO 2 , ##STR22## R 2 is independently selected from: (1) the definitions of R 1 ; (2) hydrogen; (3) phenyl; (4) substituted phenyl in which the substituents are X, Y and Z; (5) 1- or 2-naphthyl; (6) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z; (7) biphenyl; (8) substituted biphenyl in which the substituents are X, Y and Z; (9) C 1-10 alkyl; (10) substituted C 1-10 alkyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 -alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 -alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are independently selected from: (i) hydrogen, or (ii) C 1-6 alkyl unsubstituted or substituted with one or more of the substituent(s) selected from: (a') phenyl, which may be substituted with X, Y and Z, (b') --OH, (c') C 1-6 alkoxy, (d') --CO 2 H, (e') --CO 2 --C 1-6 alkyl, (f') --C 3-7 cycloalkyl, and (g') -OR 11 , (iii) or where R 9 and R 10 and the N to which they are attached may form a heterocyclic ring selected from the group consisting of: morpholine, thiomorpholine, piperidine, and piperazine, (h)--NR 9 CO--C 1-6 alkyl--R 10 , wherein R 9 and R 10 are as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-napthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (11) C 3-10 alkenyl; (12) substituted C 3-10 alkenyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 -alkoxy; (d) phenyl-C 1-3 alkoxy; (e) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z; (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (13)C 3-10 alkynyl; (14) substituted C 3-10 alkynyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 -alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --N 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 -alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 ; and (15) --R 11 ; R 6 is selected from the group consisting of: (1) hydrogen, (2) C 1-6 -alkyl, unsubstituted or substituted with: (a) hydroxy, (b) C 1-6 alkoxy, (c) --N 12 R 13 , wherein R 12 and R 13 are independently selected from (i) hydrogen, (ii) C 1-6 alkyl, or (iii) C 3-6 alkenyl, (d) phenyl, unsubstituted or substituted with X, Y and Z, (e) --OR 11 , (3) C 3-6 alkenyl, unsubstituted or substituted with: (a) hydroxy, (b) phenyl, unsubstituted or substituted with X, Y and Z, or (c) C 1-6 alkoxy, (4) phenyl, unsubstituted or substituted with X, Y and Z, (5) --R 11 , (6) X, Y or Z; R 7 and R 8 independently are selected from the group consisting of: (1) hydrogen, (2) C 1-7 alkyl, (3) C 2-6 alkenyl, (4) --(CH 2 ) m --NR 9 R 10 , wherein R 9 and R 10 are as defined above, and m is 0, 1, 2, and 3, (5) --CF 3 , (6) --CONR 9 R 10 , wherein R 9 and R 10 are as defined above, (7) R 14 O(CH 2 ) m -- wherein R 14 is hydrogen, C 1-6 alkyl, hydroxy--C 2-3 alkyl, --CF 3 , phenyl, R 11 or naphthyl and m is as defined above, (8) ##STR23## wherein R 14 and m are as defined above; (9) phenyl--(CH 2 ) m -- wherein m is as defined above and the phenyl is unsubstituted or substituted with X, Y and Z, (10) napthyl--(CH 2 ) m -- wherein m is as defined above and the napthyl is unsubstituted or substituted with X, Y and Z, (11) biphenyl--(CH 2 ) m -- wherein m is as defined above and the biphenyl is unsubstituted or substituted with X, Y and Z, (12) heteroaryl--(CH 2 ) m -- wherein heteroaryl is selected from: acridine, carbazole, cinnoline, dibenzofuran, dibenzothiophene, quinozaline, pyrrazole, indole, imidazole, benzatriazole, furan, benzofuran, quinoline, isoquinoline, pyrazine, pyridazine, pyridine, pyrimidine, and pyrrole, m is as defined above and the heteroaryl is unsubstituted or substituted with X, Y, and Z, (13) morpholinyl, and (14) --CH═CH--phenyl wherein the phenyl is unsubstituted or substituted with X, Y and Z; R 11 is selected from: (a) --PO(OH)O - M + , wherein M + is a positively charged inorganic or organic counterion, selected from the group consisting of: ammonium, sodium, lithium, potassium, calcium, magnesium, dicyclohexylamine, N-methyl-D-glucamine, arginine and lysine, (b) --SO 3 - M + , (c) --CO(CH 2 ) q CO 2 - M + , wherein q is 1 to 3, and (d) --CO--C 1-6 alkyl--NR 9 R 10 , wherein R 9 and R 10 are as defined above and the alkyl is unsubstituted or substituted with one or more substituents selected from: (i) hydrogen, (ii) C 1-6 alkoxy, (iii) --NR 12 R 13 , wherein R 12 and R 13 are as defined above, (iv) --COOR 6 , wherein R 6 is as defined above, (v) phenyl, (vi) substituted phenyl in which the substituents are X, Y and Z, (vii) imidazolidyl, (viii) indolyl, (ix) --SH, and (x) --S--C 1-6 alkyl; A is selected from the group consisting of: (1) a bond, (2) C 1-10 alkyl; (3) substituted C 1-10 alkyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l ) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (4) --C 1-10 alkyl wherein one or more of the alkyl carbons is replaced by a group selected from: --NR 9 --, --O--, --S(O) p --, --CO 2 --, --O 2 C--, --CONR 9 --, --NR 9 CO--, --NR 9 CONR 10 --; (5) --C 3-10 alkenyl wherein alkenyl contains one to four double bonds and wherein one or more of the alkyl carbons is replaced by a group selected from: --NR 9 --, --O--, --S(O) n --, --CO 2 C--, --CONR 9 --, --NR 9 CO--, and --NR 9 CONR 10 --; ##STR24## wherein s is 0 to 6 and t is 0 to 6, ##STR25## wherein r is 1 to 3 and s, and t are as defined above; X, Y and Z are independently selected from the group consisting of: (a) hydrogen, (b) C 1-10 alkyl, unsubstituted or substituted with one or more substituents selected from: (i) aryl, wherein aryl is selected from the group consisting of phenyl and naphthyl, (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z', (iii) heteroaryl, wherein heteroaryl is as defined above, (iv) substituted heteroaryl wherein heteroaryl is as defined above in which the substituents are X', Y', and Z', (v) unsubstituted or substituted aryloxy, wherein aryl is as defined above and in which the substituents on aryl are X', Y' and Z', (vi) --OR 9 , (vii) --OR 11 , (viii) --OCOR 9 , (ix) --OCO 2 R 9 , (x) --NR 9 R 10 , (xi) --CHO, (xii) --NR 9 COC 1-6 alkyl-R 10 , (xiii) --NR 9 CO 2 C 1-6 alkyl-R 10 , (xiv) --NR 9 CONR 9 R 10 , (xv) --OCONR 9 R 10 , (xvi) --CONR 9 R 10 , (c) C 1-10 alkyl wherein one or more of the alkyl carbons is replaced by a group selected from --NR 9 --, --O--, --S(O) p --, --CO 2 --, --O 2 C--, --CONR 9 --, --NR 9 CO--, --NR 9 CONR 10 --, --CO--, --CH(OH)--, alkenyl or alkynyl and the alkyl may be unsubstituted or substituted with one or more substituents selected from: (i) aryl, wherein aryl is as defined above, (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z', (iii) heteroaryl, wherein heteroaryl is as defined above, (iv) substituted heteroaryl wherein heteroaryl is as defined above and in which the substituents are X', Y', and Z', (v) unsubstituted or substituted aryloxy, in which the substituents on aryl are X', Y', and Z', (vi) --OR 9 , (vii) --OR 11 , (viii) --OCOR 9 , (ix) --OCO 2 R 9 , (x) --NR 9 R 10 , (xi) --CHO, (xii) --NR 9 COC 1-6 alkyl-R 10 , (xiii) --NR 9 CO 2 C 1-6 alkyl-R 10 , (xiv) --NR 9 CONR 9 R 10 , (xv) --OCONR 9 R 10 , (xvi) --CONR 9 R 10 , (d) halogen, (e) --NR 9 R 10 , (f) --CN, (g) --CHO, (h) --CF 3 , (i) --SR 15 , wherein R 15 is hydrogen, C 1-6 alkyl, trifluoromethyl, or phenyl, (j) --SOR 15 , (k) --SO 2 R 15 , (l) --CONR 9 R 10 , (m) R 16 O(CH 2 ) m -- wherein R 16 is hydrogen, C 1-6 alkyl, hydroxy-C 2-3 alkyl, --CF 3 , phenyl, R 11 or naphthyl and m is 0, 1, 2, or 3, (n) --CH(OR 17 )(OR 18 ), wherein R 17 and R 18 are C 1-3 alkyl or taken together form an ethyl or propyl bridge, (o) ##STR26## wherein R 16 and m are as defined above, (p) ##STR27## wherein R 16 and m are as defined above, and (q) --R 11 ; or any two of X, Y and Z may be joined to form a saturated ring having 5, 6 or 7 ring atoms, said ring atoms comprising 1 or 2 oxygen atoms, the remaining ring atoms being carbon; X', Y' and Z' independently are selected from: (a) hydrogen, (b) C 1-7 alkyl, (c) C 2-6 alkenyl, (d) halogen, (e) --(CH 2 ) m --NR 9 R 10 , wherein R 9 , R 10 and m are as defined above, (f) --CN, (g) --CHO, (h) --CF 3 , (i) --SR 15 , wherein R 15 is as defined above, (j) --SOR 15 , wherein R 15 is as defined above, (k) --SO 2 R 15 , wherein R 15 is as defined above, (l) --CONR 9 R 10 , wherein R 9 and R 10 are as defined above, (m) R 16 O(CH 2 ) m --, wherein R 16 and m are as defined above, (n) --CH(OR 17 )(OR 18 ), wherein R 17 and R 18 are as defined above, (o) ##STR28## wherein R 16 and m are as defined above, (p) ##STR29## wherein R 16 and m are as defined above, and (q) --R 11 .
Claim 2
Dependent Claim
2135 words
A compound of formula I: ##STR20## or a pharmaceutically acceptable salt thereof, wherein: R 1 is selected from the group consisting of: ##STR21## wherein G is N--R 6 , O, S, SO, or SO 2 , ##STR22## R 2 is independently selected from: (1) the definitions of R 1 ; (2) hydrogen; (3) phenyl; (4) substituted phenyl in which the substituents are X, Y and Z; (5) 1- or 2-naphthyl; (6) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z; (7) biphenyl; (8) substituted biphenyl in which the substituents are X, Y and Z; (9) C 1-10 alkyl; (10) substituted C 1-10 alkyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 -alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 -alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are independently selected from: (i) hydrogen, or (ii) C 1-6 alkyl unsubstituted or substituted with one or more of the substituent(s) selected from: (a') phenyl, which may be substituted with X, Y and Z, (b') --OH, (c') C 1-6 alkoxy, (d') --CO 2 H, (e') --CO 2 --C 1-6 alkyl, (f') --C 3-7 cycloalkyl, and (g') -OR 11 , (iii) or where R 9 and R 10 and the N to which they are attached may form a heterocyclic ring selected from the group consisting of: morpholine, thiomorpholine, piperidine, and piperazine, (h)--NR 9 CO--C 1-6 alkyl--R 10 , wherein R 9 and R 10 are as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-napthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (11) C 3-10 alkenyl; (12) substituted C 3-10 alkenyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 -alkoxy; (d) phenyl-C 1-3 alkoxy; (e) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z; (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (13)C 3-10 alkynyl; (14) substituted C 3-10 alkynyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 -alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --N 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 -alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 ; and (15) --R 11 ; R 6 is selected from the group consisting of: (1) hydrogen, (2) C 1-6 -alkyl, unsubstituted or substituted with: (a) hydroxy, (b) C 1-6 alkoxy, (c) --N 12 R 13 , wherein R 12 and R 13 are independently selected from (i) hydrogen, (ii) C 1-6 alkyl, or (iii) C 3-6 alkenyl, (d) phenyl, unsubstituted or substituted with X, Y and Z, (e) --OR 11 , (3) C 3-6 alkenyl, unsubstituted or substituted with: (a) hydroxy, (b) phenyl, unsubstituted or substituted with X, Y and Z, or (c) C 1-6 alkoxy, (4) phenyl, unsubstituted or substituted with X, Y and Z, (5) --R 11 , (6) X, Y or Z; R 7 and R 8 independently are selected from the group consisting of: (1) hydrogen, (2) C 1-7 alkyl, (3) C 2-6 alkenyl, (4) --(CH 2 ) m --NR 9 R 10 , wherein R 9 and R 10 are as defined above, and m is 0, 1, 2, and 3, (5) --CF 3 , (6) --CONR 9 R 10 , wherein R 9 and R 10 are as defined above, (7) R 14 O(CH 2 ) m -- wherein R 14 is hydrogen, C 1-6 alkyl, hydroxy--C 2-3 alkyl, --CF 3 , phenyl, R 11 or naphthyl and m is as defined above, (8) ##STR23## wherein R 14 and m are as defined above; (9) phenyl--(CH 2 ) m -- wherein m is as defined above and the phenyl is unsubstituted or substituted with X, Y and Z, (10) napthyl--(CH 2 ) m -- wherein m is as defined above and the napthyl is unsubstituted or substituted with X, Y and Z, (11) biphenyl--(CH 2 ) m -- wherein m is as defined above and the biphenyl is unsubstituted or substituted with X, Y and Z, (12) heteroaryl--(CH 2 ) m -- wherein heteroaryl is selected from: acridine, carbazole, cinnoline, dibenzofuran, dibenzothiophene, quinozaline, pyrrazole, indole, imidazole, benzatriazole, furan, benzofuran, quinoline, isoquinoline, pyrazine, pyridazine, pyridine, pyrimidine, and pyrrole, m is as defined above and the heteroaryl is unsubstituted or substituted with X, Y, and Z, (13) morpholinyl, and (14) --CH═CH--phenyl wherein the phenyl is unsubstituted or substituted with X, Y and Z; R 11 is selected from: (a) --PO(OH)O - M + , wherein M + is a positively charged inorganic or organic counterion, selected from the group consisting of: ammonium, sodium, lithium, potassium, calcium, magnesium, dicyclohexylamine, N-methyl-D-glucamine, arginine and lysine, (b) --SO 3 - M + , (c) --CO(CH 2 ) q CO 2 - M + , wherein q is 1 to 3, and (d) --CO--C 1-6 alkyl--NR 9 R 10 , wherein R 9 and R 10 are as defined above and the alkyl is unsubstituted or substituted with one or more substituents selected from: (i) hydrogen, (ii) C 1-6 alkoxy, (iii) --NR 12 R 13 , wherein R 12 and R 13 are as defined above, (iv) --COOR 6 , wherein R 6 is as defined above, (v) phenyl, (vi) substituted phenyl in which the substituents are X, Y and Z, (vii) imidazolidyl, (viii) indolyl, (ix) --SH, and (x) --S--C 1-6 alkyl; A is selected from the group consisting of: (1) a bond, (2) C 1-10 alkyl; (3) substituted C 1-10 alkyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) oxo, (c) C 1-6 alkoxy, (d) phenyl-C 1-3 alkoxy, (e) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (f) --OCO--C 1-6 alkyl, (g) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, (h) --NR 9 CO--C 1-6 alkyl, wherein R 9 is as defined above, (i) --COOR 9 , wherein R 9 is as defined above, (j) --CHO, (k) phenyl, (l ) substituted phenyl in which the substituents are X, Y and Z, (m) 1- or 2-naphthyl, (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z, (o) biphenyl, (p) substituted biphenyl in which the substituents are X, Y and Z, (q) --OR 11 , and (r) --S(O) p --C 1-6 alkyl; (4) --C 1-10 alkyl wherein one or more of the alkyl carbons is replaced by a group selected from: --NR 9 --, --O--, --S(O) p --, --CO 2 --, --O 2 C--, --CONR 9 --, --NR 9 CO--, --NR 9 CONR 10 --; (5) --C 3-10 alkenyl wherein alkenyl contains one to four double bonds and wherein one or more of the alkyl carbons is replaced by a group selected from: --NR 9 --, --O--, --S(O) n --, --CO 2 C--, --CONR 9 --, --NR 9 CO--, and --NR 9 CONR 10 --; ##STR24## wherein s is 0 to 6 and t is 0 to 6, ##STR25## wherein r is 1 to 3 and s, and t are as defined above; X, Y and Z are independently selected from the group consisting of: (a) hydrogen, (b) C 1-10 alkyl, unsubstituted or substituted with one or more substituents selected from: (i) aryl, wherein aryl is selected from the group consisting of phenyl and naphthyl, (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z', (iii) heteroaryl, wherein heteroaryl is as defined above, (iv) substituted heteroaryl wherein heteroaryl is as defined above in which the substituents are X', Y', and Z', (v) unsubstituted or substituted aryloxy, wherein aryl is as defined above and in which the substituents on aryl are X', Y' and Z', (vi) --OR 9 , (vii) --OR 11 , (viii) --OCOR 9 , (ix) --OCO 2 R 9 , (x) --NR 9 R 10 , (xi) --CHO, (xii) --NR 9 COC 1-6 alkyl-R 10 , (xiii) --NR 9 CO 2 C 1-6 alkyl-R 10 , (xiv) --NR 9 CONR 9 R 10 , (xv) --OCONR 9 R 10 , (xvi) --CONR 9 R 10 , (c) C 1-10 alkyl wherein one or more of the alkyl carbons is replaced by a group selected from --NR 9 --, --O--, --S(O) p --, --CO 2 --, --O 2 C--, --CONR 9 --, --NR 9 CO--, --NR 9 CONR 10 --, --CO--, --CH(OH)--, alkenyl or alkynyl and the alkyl may be unsubstituted or substituted with one or more substituents selected from: (i) aryl, wherein aryl is as defined above, (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z', (iii) heteroaryl, wherein heteroaryl is as defined above, (iv) substituted heteroaryl wherein heteroaryl is as defined above and in which the substituents are X', Y', and Z', (v) unsubstituted or substituted aryloxy, in which the substituents on aryl are X', Y', and Z', (vi) --OR 9 , (vii) --OR 11 , (viii) --OCOR 9 , (ix) --OCO 2 R 9 , (x) --NR 9 R 10 , (xi) --CHO, (xii) --NR 9 COC 1-6 alkyl-R 10 , (xiii) --NR 9 CO 2 C 1-6 alkyl-R 10 , (xiv) --NR 9 CONR 9 R 10 , (xv) --OCONR 9 R 10 , (xvi) --CONR 9 R 10 , (d) halogen, (e) --NR 9 R 10 , (f) --CN, (g) --CHO, (h) --CF 3 , (i) --SR 15 , wherein R 15 is hydrogen, C 1-6 alkyl, trifluoromethyl, or phenyl, (j) --SOR 15 , (k) --SO 2 R 15 , (l) --CONR 9 R 10 , (m) R 16 O(CH 2 ) m -- wherein R 16 is hydrogen, C 1-6 alkyl, hydroxy-C 2-3 alkyl, --CF 3 , phenyl, R 11 or naphthyl and m is 0, 1, 2, or 3, (n) --CH(OR 17 )(OR 18 ), wherein R 17 and R 18 are C 1-3 alkyl or taken together form an ethyl or propyl bridge, (o) ##STR26## wherein R 16 and m are as defined above, (p) ##STR27## wherein R 16 and m are as defined above, and (q) --R 11 ; or any two of X, Y and Z may be joined to form a saturated ring having 5, 6 or 7 ring atoms, said ring atoms comprising 1 or 2 oxygen atoms, the remaining ring atoms being carbon; X', Y' and Z' independently are selected from: (a) hydrogen, (b) C 1-7 alkyl, (c) C 2-6 alkenyl, (d) halogen, (e) --(CH 2 ) m --NR 9 R 10 , wherein R 9 , R 10 and m are as defined above, (f) --CN, (g) --CHO, (h) --CF 3 , (i) --SR 15 , wherein R 15 is as defined above, (j) --SOR 15 , wherein R 15 is as defined above, (k) --SO 2 R 15 , wherein R 15 is as defined above, (l) --CONR 9 R 10 , wherein R 9 and R 10 are as defined above, (m) R 16 O(CH 2 ) m --, wherein R 16 and m are as defined above, (n) --CH(OR 17 )(OR 18 ), wherein R 17 and R 18 are as defined above, (o) ##STR28## wherein R 16 and m are as defined above, (p) ##STR29## wherein R 16 and m are as defined above, and (q) --R 11 .
Claim 3
Dependent Claim
784 words
The compound of claim 1 wherein: R 1 is selected from: ##STR30## wherein G is N--R 6 , O, or S, ##STR31## R 2 is independently selected from: (1) hydrogen; (2) phenyl; (3) substituted phenyl in which the substituents are X, Y and Z; (4) C 1-10 alkyl; (5) substituted C 1-10 alkyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) C 1-6 alkoxy, (c) phenyl-C 1-3 alkoxy, (d) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (e) --OCO--C 1-6 alkyl, (f) --COOR 20 , wherein R 20 is hydrogen or C 1-6 alkyl, (g) --CHO, (h) phenyl, and (i) substituted phenyl in which the substituents are X, Y and Z, (6) C 3-10 alkenyl; (7) substituted C 3-10 alkenyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) C 1-6 alkoxy, (c) phenyl-C 1-3 alkoxy, (d) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (e) --OCO--C 1-6 alkyl, (f) --COOR 20 , wherein R 20 is as defined above, (g) --CHO, (h) phenyl, and (i) substituted phenyl in which the substituents are X, Y and Z, (8) C 3-10 alkynyl; (9) substituted C 3-10 alkenyl in which one or more substituent(s) is(are) selected from: (a) hydroxy, (b) C 1-6 alkoxy, (c) phenyl-C 1-3 alkoxy, (d) substituted phenyl-C 1-3 alkoxy, in which the substituents on phenyl are X, Y and Z, (e) --OCO--C 1-6 alkyl, (f) --COOR 9 , wherein R 9 is as defined above, (g) --CHO, (h) phenyl, (i) substituted phenyl in which the substituents are X, Y and Z; and (10) --R 11 ; R 6 is selected from the group consisting of: (1) hydrogen; (2) C 1-6 alkyl, unsubstituted or substituted with: (a) hydroxy, (b) C 1-6 alkoxy, (c) phenyl, substituted or unsubstituted with X, Y and Z, (d) --OR 11 , (3) C 3-6 alkenyl, unsubstituted or substituted with: (a) hydroxy, (b) phenyl, unsubstituted or substituted with X, Y and Z, or (c) C 1-6 alkoxy, and (4) phenyl, unsubstituted or substituted with X, Y and Z, (5) --R 11 , (6) X, Y or Z; R 7 and R 8 independently are selected from the group consisting of: (1) hydrogen; (2) C 1-7 alkyl, (3) C 2-6 alkenyl, (4) --CF 3 , (5) R 14 O(CH 2 ) m -- wherein R 14 is hydrogen, C 1-6 alkyl, hydroxy-C 2-3 alkyl, --CF 3 , phenyl, R 11 or naphthyl and m is 0, 1, 2 or 3 (6) ##STR32## wherein R 14 and m are as defined above; (7) phenyl-(CH 2 ) m -- wherein m is as defined above and the phenyl is unsubstituted or substituted with X, Y and Z, (8) heteroaryl--(CH 2 ) m -- wherein heteroaryl is selected from: acridine, carbazole, cinnoline, dibenzofuran, dibenzothiophene, quinozaline, pyrrazole, indole, imidazole, benzotriazole, furan, benzofuran, quinoline, isoquinoline, pyriazine, pyridazine, pyridine, pyrimidine, and pyrrole, m is as defined above and the heteroaryl is unsubstituted or substituted with X, Y and Z, and (9) --CH═CH--phenyl wherein the phenyl is unsubstituted or substituted with X, Y and Z; R 11 is selected from: (a) --PO(OH)O - M + , wherein M + is a positively charged inorganic or organic counterion, selected from the group consisting of: ammonium, sodium, lithium, potassium, calcium, magnesium, dicyclohexylamine, N-methyl-D-glucamine, arginine and lysine, (b) --SO 3 - M + , (c) --CO(CH 2 ) q CO 2 - M + , wherein q is 1 to 3, and (d) --CO--C 1-6 alkyl-NR 20 R 21 , wherein R 20 is as defined above and R 21 is selected from the definitions of R 20 ; A is selected from the group consisting of: (1) a bond, (2) C 1-10 alkyl, and (3) ##STR33## wherein s is 0 to 2 and t is 0 to 2; X, Y and Z are independently selected from the group consisting of: (a) hydrogen; (b) C 1-7 alkyl, (c) C 2-6 alkenyl, (d) halogen, (e) --(CH 2 ) m --NR 20 R 21 , wherein R 20 , R 21 and m are as defined above, (f) --(CH 2 ) m --CONR 20 R 21 , wherein R 20 , R 21 and m are as defined above, (g) --(CH 2 ) m --NR 20 --COR 14 , wherein R 14 , R 20 and m are as defined above, (h) --O--(CH 2 ) m --CONR 20 R 21 , wherein R 20 , R 21 and m are as defined above, (i) --CN, (j) --CHO, (k) --CF 3 , (l) R 14 O(CH 2 ) m -- wherein R 14 and m are as defined above, (m) --R 11 .
Claim 4
Dependent Claim
94 words
The compound of claim 1 wherein: R 1 is: ##STR34## R 2 is hydrogen or methyl; R 6 is hydrogen, methyl, benzyl, 3-fluorobenzyl, R 11 or --C 1-4 alkyl-OR 11 ; R 7 and R 8 are independently selected from hydrogen, methyl, CH 3 OCH 2 --, HOCH 2 --, phenyl, 3,5-difluorophenyl, 3-fluorophenyl, 3,4-difluorophenyl, 3,5-dichlorophenyl, 3-methoxyphenyl, 3-trifluoromethylphenyl, 3-hydroxyphenyl, 4-hydroxyphenyl, 3,5-dihydroxyphenyl 4-tert-butylphenyl, 3,4-methylenedioxyphenyl, 3,5-trifluoromethylphenyl, 4-methoxyphenyl, 3,5-dimethoxyphenyl, 3-trifluoromethoxyphenyl, 3,5-di(trifluoromethoxy)phenyl, 2-methoxyphenyl, 3-isopropyloxyphenyl, 3-ethoxyphenyl, 3,5-diethoxyphenyl, 3,4,5-trimethoxyphenyl, 3-hydorxyethyloxyphenyl, 3-propyloxyphenyl, 3-isobutyloxyphenyl, 3-methylphenyl, 3,5-dimethylphenyl, 3-ethylphenyl, 3,5-diethylphenyl, and phenylethyl; A is --CH 2 --, phenyl, or benzyl; and pharmaceutically acceptable salts thereof.
Claim 5
Dependent Claim
126 words
A compound which is: ##STR35## wherein R 1 and R 2 are selected from the following combinations of substituents: __________________________________________________________________________
R.sup.1 R.sup.2
__________________________________________________________________________
(a)
##STR36## H
(b)
##STR37## H
(c)
##STR38## H
(d)
##STR39## H
(e)
H
##STR40##
(f)
##STR41## H
(g)
##STR42## H
(h)
##STR43## H
(i)
H
##STR44##
(j)
H
##STR45##
(k)
H
##STR46##
(l)
##STR47## H
(m)
##STR48## H
(n)
##STR49## H
(o)
H
##STR50##
(p)
H
##STR51##
(q)
H
##STR52##
(r)
##STR53## H
(s)
H
##STR54##
(t)
##STR55## H
(u)
H
##STR56##
(v)
##STR57## H
(w)
##STR58## H
(x)
##STR59## H
(y)
##STR60## H
(z)
##STR61## H
(aa)
H
##STR62##
(bb)
##STR63## H
(cc)
##STR64## H
(dd)
##STR65## H
(ee)
##STR66## H
(ff)
##STR67## H
(gg)
##STR68## H
(hh)
##STR69## H.
__________________________________________________________________________
Claim 6
Dependent Claim
126 words
A compound which is: ##STR35## wherein R 1 and R 2 are selected from the following combinations of substituents: __________________________________________________________________________
R.sup.1 R.sup.2
__________________________________________________________________________
(a)
##STR36## H
(b)
##STR37## H
(c)
##STR38## H
(d)
##STR39## H
(e)
H
##STR40##
(f)
##STR41## H
(g)
##STR42## H
(h)
##STR43## H
(i)
H
##STR44##
(j)
H
##STR45##
(k)
H
##STR46##
(l)
##STR47## H
(m)
##STR48## H
(n)
##STR49## H
(o)
H
##STR50##
(p)
H
##STR51##
(q)
H
##STR52##
(r)
##STR53## H
(s)
H
##STR54##
(t)
##STR55## H
(u)
H
##STR56##
(v)
##STR57## H
(w)
##STR58## H
(x)
##STR59## H
(y)
##STR60## H
(z)
##STR61## H
(aa)
H
##STR62##
(bb)
##STR63## H
(cc)
##STR64## H
(dd)
##STR65## H
(ee)
##STR66## H
(ff)
##STR67## H
(gg)
##STR68## H
(hh)
##STR69## H.
__________________________________________________________________________
Claim 7
Dependent Claim
5 words
A compound which is: 42-(4'-phenyl-2'-imidazoylymethyloxy)-rapamycin.
Claim 8
Dependent Claim
5 words
A compound which is: 42-(4'-phenyl-2'-imidazoylymethyloxy)-rapamycin.
References Cited (Backward Citations)
US3929992A
Cited
US4650803A
Cited
EP0227355A2
Cited
WO1989005304A1
Cited
WO1991002736A1
Cited
WO1991013889A1
Cited
GB2245891A
Cited
WO1992005179A1
Cited
WO1992014737A1
Cited
US5120842A
Cited
US5120842B1
Cited
US5100883A
Cited
US5118678A
Cited
US5102876A
Cited
US5162334A
Cited
WO1992020688A1
Cited
US5118677A
Cited
US5120725A
Cited
EP0516347A1
Cited
US5120727A
Cited
WO1992021341A1
Cited
US5138051A
Cited
US5169851A
Cited
WO1993005058A1
Cited
WO1993005059A1
Cited
US5162333A
Cited
US5151413A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-05-09 | 1997-11-08 | 1998-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-05-09 | 2001-11-08 | 2002-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-05-09 | 2005-11-08 | 2006-05-10 | $7700.00 | Window Closed / Lapsed |